Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

Universal heart screening for all athletes? Not so fast, cardiologists warn
Mandates for universal ECG screening are gaining momentum as a way to combat the risk of SCA. However, the ACC warned, modern healthcare systems were not built to withstand such a rise in demand. These mandates will also result in higher costs and other unintended consequences.
AI-powered lung cancer screening support tool nabs FDA clearance
The software was designed to address issues with inter-reader variability common to LDCT screenings.
Men developed CVD earlier than women, according to 35-year CARDIA study
Promoting preventive care among young adult men during critical periods of their life may be the key to reducing rates of cardiovascular disease.
AI model turns POCUS images into accurate structural heart evaluations
Researchers see potential for this technology to make cardiac screening much easier for physicians who are not trained cardiologists.
Microsoft and Bristol Myers Squibb partner to advance AI-enabled lung cancer detection
Lung cancer remains the leading cause of cancer-related deaths in the United States. It is estimated that it claims approximately 125,000 lives in the U.S. every year.

Universal heart screening for all athletes? Not so fast, cardiologists warn

Mandates for universal ECG screening are gaining momentum as a way to combat the risk of SCA. However, the ACC warned, modern healthcare systems were not built to withstand such a rise in demand. These mandates will also result in higher costs and other unintended consequences.

AI-powered lung cancer screening support tool nabs FDA clearance

The software was designed to address issues with inter-reader variability common to LDCT screenings.

Men developed CVD earlier than women, according to 35-year CARDIA study

Promoting preventive care among young adult men during critical periods of their life may be the key to reducing rates of cardiovascular disease.

AISAP, an Israeli healthcare technology company focused on using artificial intelligence (AI) to enhance medical imaging results, has gained U.S. Food and Drug Administration (FDA) clearance for its new point-of-care ultrasound (POCUS) software platform, AISAP Cardio.

AI model turns POCUS images into accurate structural heart evaluations

Researchers see potential for this technology to make cardiac screening much easier for physicians who are not trained cardiologists.

Microsoft and Bristol Myers Squibb partner to advance AI-enabled lung cancer detection

Lung cancer remains the leading cause of cancer-related deaths in the United States. It is estimated that it claims approximately 125,000 lives in the U.S. every year.

The U.S. Food and Drug Administration (FDA) has cleared HeartLung Corporation's AI-CVD, an artificial intelligence (AI) algorithm that looks at 11 different opportunistic health screening assessments on chest CT exams ordered for any reason.

FDA clears opportunistic AI for detecting cardiothoracic issues in CT scans

“Coronary calcium revealed long ago that atherosclerosis begins well before symptoms. AI-CVD extends that insight by enabling systematic identification of patients who are unaware of their cardiovascular risk using CT scans that already exist,” said Arthur Agatston, MD.

CT colonography the most cost-effective cancer screening option for many

Findings from the Neiman Health Policy Institute and Northwell Health indicate that CTC is especially beneficial for underserved populations.

Beyond just nodules—model uses all low-dose CT data to make long-term lung cancer risk predictions

New findings published in RSNA's Radiology highlight the shortcomings of using nodule characteristics and patient history alone to predict an individual’s true cancer risk.